Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 215

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Progression of Coronary Artery Disease Predicts Clinical Coronary Events: Long-term Follow-up From the Cholesterol Lowering Atherosclerosis Study

Azen, Stanley P., Mack, Wendy J., Cashin-Hemphill, Linda, LaBree, Laurie, Shircore, Anne M., Selzer, Robert H., Blankenhorn, David H., Hodis, Howard N. · 1996 · Circulation

Abstract

Background Progression of coronary artery disease is assumed to be a surrogate end point for clinical coronary events. Because no single method or measure for a coronary angiographic end point is uniformly accepted as optimal, the utility and validity of surrogate end points for predicting clinical coronary events remain unsettled. Methods and Results The Cholesterol Lowering Atherosclerosis Study randomized 162 nonsmoking, 40- to 59-year-old men with previous coronary artery bypass graft surgery to colestipol/niacin plus diet or placebo plus diet. Atherosclerosis change on 2-year coronary angiograms was evaluated by a consensus panel and by quantitative coronary angiography (average per-subject change in percent diameter stenosis [%S] and minimum lumen diameter [MLD]). With all three end points, the benefit of colestipol/niacin treatment on coronary artery atherosclerosis has been reported. Annual follow-up for an average of 7 years (range, 6.3 months to 10 years) has been carried out on all subjects who completed the 2-year angiogram. Clinical coronary events (need for revascularization, nonfatal acute myocardial infarction, and coronary death) have been documented. Risk of clinical coronary events was positively related to coronary lesion progression for all three surrogate end points ( P <.05). New lesion formation in bypass grafts ( P =.02) and progression of mild/moderate lesions (<50%S) were predictive of clinical coronary events ( P <.01). Change in MLD contributed significantly to the prediction of clinical coronary events beyond a model with %S alone ( P <.05). Conclusions In this population of nonsmoking men with previous bypass surgery, both the consensus panel– and quantitative coronary angiography–based end points of coronary artery disease progression predict clinical coronary events. Subjects who demonstrate greater coronary artery lesion progression have an increased risk of future clinical coronary events. Design of shorter, smaller trials of antiatherosclerotic agents is justified.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.cir.93.1.34

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 215

Metadata

Authors
Azen, S. P., Mack, W. J., Cashin-Hemphill, L., LaBree, L., Shircore, A. M., Selzer, R. H., Blankenhorn, D. H., & Hodis, H. N.
Venue
Circulation
Published
1996-01
Volume
93
Issue
1
Pages
34-41
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2003188915
Cited by
215
References
6
FWCI
20.00
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Progression of Coronary Artery Disease Predicts Clinical Coronary Events: Long-term Follow-up From the Cholesterol Lowering Atherosclerosis Study. https://app.cochat.ai/papers/10.1161/01.cir.93.1.34
The paper
Azen, S. P., Mack, W. J., Cashin-Hemphill, L., LaBree, L., Shircore, A. M., Selzer, R. H., Blankenhorn, D. H., & Hodis, H. N. (1996). Progression of Coronary Artery Disease Predicts Clinical Coronary Events: Long-term Follow-up From the Cholesterol Lowering Atherosclerosis Study. Circulation. https://doi.org/10.1161/01.cir.93.1.34

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.